SBIR/STTR Research Award

Engineering probiotics to biosynthesize natural substances for microbiome brain research

Award identifier 9bcfe82e84d594599022dc42e7faa10ed09a0cc1c287ad54a29d22a48800cc55Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$224,999

Program and phase

STTR · Phase I

Award year

2017

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
HGG Research LLC
Proposal award date
2017-06-01
Contract end date
2020-05-31
UEI
GRUBC16PUKX5
Solicitation number
DA17-016
Topic code
R

Research abstract

PROJECT SUMMARY To advance microbiome brain studies the general goals of this collaborative proposal are to provide services to research community by engineering probiotics e g E coli Nissle EcN Bifidobacteria longum Lactobacillus plantarum to biosynthesize various naturally occurring chemicals as prebiotic probiotic conjugates which will be marketed as important laboratory agents to study the effects of natural products on neurological diseases by modulating gut microbiome As a proof of concept EcN that produces high levels of hydroxytryptophan HTP a natural biosynthetic precursor of serotonin will be fed to mice to evaluate its bioavailability pharmacokinetic tolerability modulation of microbiome and toxicity We have recently developed a novel microbial approach for HTP production by rationally engineering a phenylalanine hydroxylase into a tryptophan hydroxylase and reconstituting a novel HTP biosynthetic mechanism in a model microorganism E coli K derivative The proposed research in phase I will focus on Aim testing whether the novel microbial approach for producing high level HTP in the E coli strain BW can be utilized in the probiotic strain EcN HTP EcN and Aim on testing that the HTP EcN has no adverse effects and the produced HTP is biologically available We choose EcN as the host strain because its safety has been well documented and it can directly interact with mucosal dendritic cells in the gut and promote the absorbance of biomolecules biosynthesized by itself Furthermore it can reside in the gut for weeks and realize controlled release and sustained delivery of biosynthesized compounds HGG Research LLC is a company that will develop methods to synthesize various natural compounds in probiotic strains Research by the academic partner currently at the University of Georgia will evaluate the bioavailability modulation of microbiome and toxicity The design of studies by expressing various phytochemicals in different probiotic strains using an inducer free expression system in a mouse model would be the next stage following this STTR project Biosynthesis of natural products by probiotics in gut has several advantages compared to oral feeding of these compounds We believe that the proposed research is innovative and of great significance and represents a frontier in health research metabolic engineering and synthetic biology with implications in biology chemistry and engineering PROJECT NARRATIVE The gut brain axis is now recognized as a regulator of mood cognition pain sleep and eating behavior Probiotics have been used in modulating gut microbiota to prevent and treat a variety of diseases and disorders including those that are associated with the gut brain axis Gut microflora can function as the vectors for generating and delivering various types of naturally occurring beneficial compounds Furthermore natural products have been studied widely for their preventive complementary treatments for various neurological diseases and they can modulate microbiome To advance microbiome brain studies the general goals of this collaborative proposal are to provide services to research community by engineering probiotics e g E coli Nissle EcN Bifidobacteria longum Lactobacillus plantarum to biosynthesize various naturally occurring chemicals as prebiotic probiotic conjugates which will be marketed as important laboratory agents to study the effects of natural products on neurological diseases by modulating gut microbiome The proposed research will lead to the development of food grade genetic tools and techniques that can have much broader applications in engineering many other probiotics which will greatly improve our capability of manipulating probiotics for health related use

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

2 SBIR/STTR records share this UEI (2017–2019). Reported award amounts total $463,999. Reported amounts are not federal obligations.

Phases: Phase I

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.